BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38629833)

  • 1. Current obstetric outcomes in Jamaican women with sickle hemoglobinopathy - a balance of risks for aspirin?
    Gibson SMP; Hunter TA; Charles PE; Morgan MAC; Griffith-Anderson SKR; Cruickshank JK; Gossell-Williams MD; Johnson NA
    J Perinat Med; 2024 Jun; 52(5):485-493. PubMed ID: 38629833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pattern of sickle cell disease in pregnancy in Lagos, Nigeria.
    Ogedengbe OK; Akinyanju O
    West Afr J Med; 1993; 12(2):96-100. PubMed ID: 8398940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative studies of live neonates in maternal sickle cell haemoglobinopathy in Ghana.
    Addai FK; Wilson JB; Quashie FJ
    Trop Geogr Med; 1992 Oct; 44(4):312-6. PubMed ID: 1295139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic versus selective blood transfusion for sickle cell disease in pregnancy.
    Okusanya BO; Oladapo OT
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010378. PubMed ID: 28005272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does first-trimester serum pregnancy-associated plasma protein A differ in pregnant women with sickle cell disease?
    Peeva G; Oakley L; von Rège I; Nicolaides K; Oteng-Ntim E
    Prenat Diagn; 2019 Sep; 39(10):921-924. PubMed ID: 31240733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy outcome in homozygous sickle cell disease: observations from the Jamaican Birth Cohort.
    Lewis G; Thame M; Howitt C; Hambleton I; Serjeant GR
    BJOG; 2021 Sep; 128(10):1703-1710. PubMed ID: 33683802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse clinical and obstetric outcomes among pregnant women with different sickle cell disease genotypes.
    Silva FAC; Ferreira ALCG; Hazin-Costa MF; Dias MLG; Araújo AS; Souza AI
    Int J Gynaecol Obstet; 2018 Oct; 143(1):89-93. PubMed ID: 30030929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic versus selective blood transfusion for sickle cell disease in pregnancy.
    Okusanya BO; Oladapo OT
    Cochrane Database Syst Rev; 2013 Dec; (12):CD010378. PubMed ID: 24297507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case Report: Obstetric and COVID-19-Related Morbidity and Mortality in Three Patients with Sickle Hemoglobinopathy.
    Gibson S; Hunter T; Johnson N
    Am J Trop Med Hyg; 2024 Jun; 110(6):1198-1200. PubMed ID: 38653217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pattern of pregnancy weight gain in homozygous sickle cell disease and effect on birth size.
    Thame M; Lewis J; Hambleton I; Trotman H; Serjeant G
    West Indian Med J; 2011 Jan; 60(1):36-40. PubMed ID: 21809709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy in patients with sickle cell disease: maternal and perinatal outcomes.
    Costa VM; Viana MB; Aguiar RA
    J Matern Fetal Neonatal Med; 2015 Apr; 28(6):685-9. PubMed ID: 24866352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary Obstetric and Neonatal Outcomes in Sickle Cell Disease: A Retrospective Cohort Study.
    Hachey SM; Joseph S; Dolin CD; Triebwasser JE; Sayani F; Hamm RF
    Am J Perinatol; 2024 May; 41(S 01):e2291-e2298. PubMed ID: 37494482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct maternal and fetal pregnancy outcomes in women with sickle cell disease can be predicted using routine clinical and laboratory data.
    Malinowski AK; Kuo KHM; Tomlinson GA; Palcu P; Ward R; Shehata N
    Br J Haematol; 2021 Sep; 194(6):1063-1073. PubMed ID: 34124774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose aspirin for preventing intrauterine growth restriction and pre-eclampsia in sickle cell pregnancy (PIPSICKLE): a randomised controlled trial (study protocol).
    Afolabi BB; Babah OA; Adeyemo TA; Odukoya OO; Ezeaka CV; Nwaiwu O; Oshodi YA; Ogunnaike BA
    BMJ Open; 2021 Aug; 11(8):e047949. PubMed ID: 34389570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse maternal and perinatal outcomes in pregnant women with sickle cell disease: systematic review and meta-analysis.
    Oteng-Ntim E; Meeks D; Seed PT; Webster L; Howard J; Doyle P; Chappell LC
    Blood; 2015 May; 125(21):3316-25. PubMed ID: 25800049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal morbidity and mortality associated with mode of delivery in sickle cell disease.
    Martinborough T; Allen-Davis W; Hunter-Greaves T; Thame M; Reid M; Simms-Stewart D
    J Obstet Gynaecol; 2022 Nov; 42(8):3560-3567. PubMed ID: 36541410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
    Rankine-Mullings AE; Nevitt SJ
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD002202. PubMed ID: 36047926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy outcome in patients with sickle cell disease in the UK--a national cohort study comparing sickle cell anaemia (HbSS) with HbSC disease.
    Oteng-Ntim E; Ayensah B; Knight M; Howard J
    Br J Haematol; 2015 Apr; 169(1):129-37. PubMed ID: 25522142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute chest syndrome in adult Afro-Caribbean patients with sickle cell disease. Analysis of 81 episodes among 53 patients.
    van Agtmael MA; Cheng JD; Nossent HC
    Arch Intern Med; 1994 Mar; 154(5):557-61. PubMed ID: 8122949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy outcomes among patients with sickle cell disease at Korle-Bu Teaching Hospital, Accra, Ghana: retrospective cohort study.
    Wilson NO; Ceesay FK; Hibbert JM; Driss A; Obed SA; Adjei AA; Gyasi RK; Anderson WA; Stiles JK
    Am J Trop Med Hyg; 2012 Jun; 86(6):936-42. PubMed ID: 22665597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.